Survival Outcomes of Patients with Primary Plasma Cell Leukemia in the Era of Proteasome Inhibitors and Immunomodulatory Agents: A Real-Life Multicenter Analysis.

Creative Commons License

Atas U., Salim O., Iltar U., Yucel O. K., Kucukdiler Eroglu A. H., Aslan V., ...Daha Fazla

Turkish journal of haematology : official journal of Turkish Society of Haematology, 2024 (SCI-Expanded) identifier